Caplin Point Laboratories has appointed M Panjatcharam (who was previously the Head of R&D - Quality at Sun Pharmaceuticals Industries) as a Whole-time Director of Caplin Steriles (Wholly Owned Subsidiary Company) and as Head of Quality, R&D and Operations for the Company's regulated markets injectable business, including US FDA approved injectable plant and DSIR recognised R&D Units CP4 & CP 5, which is now Caplin Steriles.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
